Manifesto for a European Anxiety Disorders Research Network

Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initia...

Full description

Saved in:
Bibliographic Details
Published in:European neuropsychopharmacology 2010-06, Vol.20 (6), p.426-432
Main Authors: Baldwin, David S, Allgulander, Christer, Altamura, Alfredo Carlo, Angst, Jules, Bandelow, Borwin, den Boer, Johan, Boyer, Patrice, Davies, Simon, dell'Osso, Bernardo, Eriksson, Elias, Fineberg, Naomi, Fredrikson, Mats, Herran, Andres, Maron, Eduard, Metspalu, Andres, Nutt, David, van der Wee, Nic, Vázquez-Barquero, Jose Luis, Zohar, Joseph
Format: Article
Language:English
Subjects:
Anti-Anxiety Agents - therapeutic use
Anxiety disorders
Anxiety Disorders - complications
Anxiety Disorders - diagnosis
Anxiety Disorders - economics
Anxiety Disorders - epidemiology
Anxiety Disorders - therapy
Comorbidity
Consensus
Cost of Illness
Culture
Europe - epidemiology
Farmakologi och toxikologi
Humans
Internal Medicine
Multicenter Studies as Topic
network
Outcomes
Pharmacology and Toxicology
Psychiatry
Psychology
Psykologi
Public Health
Research network
Research Support as Topic
SAMHÄLLSVETENSKAP
SOCIAL SCIENCES
Socialvetenskap
Treatment
Treatment Failure
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives.
ISSN:0924-977X
1873-7862
1873-7862
DOI:10.1016/j.euroneuro.2010.02.015